化工社化工社 化学情報印刷レポート · 研究参考用
HRID 2081043作成日:2026年10月26日
Ethylmorpholine → N-{[2-fluoro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-4-imidazolidinecarboxamide
https://huagongshe.com/reaction/2081043
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Ethylmorpholine | HCID 7525 | — |
| 反応物 | (S)-(-)-2-Oxo-1,5-imidazolidinedicarboxylic acid 1-benzyl ester | HCID 688196 | — |
| 反応物 | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| 反応物 | 2-Fluoro-3-trifluoromethylbenzylamine | HCID 2737565 | — |
| 反応物 | 1-Hydroxybenzotriazole hydrate | HCID 2796029 | — |
| 反応物 | 3-Methyl-2-oxoimidazolidine-4-carboxylic acid | HCID 55300151 | — |
| 反応物 | 1,1-Dimethylethyl 3-methyl-2-oxo-4-imidazolidinecarboxylate | HCID 67103564 | — |
| 溶媒 | Dichloromethane | HCID 6344 | — |
| 生成物 | N-{[2-fluoro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-4-imidazolidinecarboxamide | HCID 59252107 | 8.4% |
反応手順
A mixture of 3-methyl-2-oxo-4-imidazolidinecarboxylic acid (86 mg, 0.6 mmol) (prepared as described in Example 28 from 1,1-dimethylethyl 3-methyl-2-oxo-4-imidazolidinecarboxylate, itself prepared as described in step (iii) of Example 13, starting originally from (4S)-2-oxo-3-{[(phenylmethyl)oxy]carbonyl}-4-imidazolidinecarboxylic acid), N-ethyl morpholine (0.380 ml, 3.00 mmol), 1-hydroxybenzotriazole hydrate (110 mg, 0.720 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (138 mg, 0.720 mmol) in dichloromethane (9 ml) was stirred at room temperature for 10 minutes, under an argon atmosphere. {[2-Fluoro-3-(trifluoromethyl)phenyl]methyl}amine (0.1 ml, 0.684 mmol) was added and the reaction was stirred overnight under an argon atmosphere. The reaction mixture was diluted with dichloromethane (10 ml) and the solution was washed with saturated sodium hydrogen carbonate solution (10 ml), water (10 ml), citric acid solution (10 ml) and brine (10 ml). The citric acid layer was re-extracted with dichloromethane and the dichloromethane extracts were combined, dried and evaporated. The residue was purified by mass-directed automated HPLC. Fractions containing product were collected and the solvent was evaporated in vacuo to give N-{[2-fluoro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-4-imidazolidinecarboxamide (16 mg, 8% yield) as a white solid. LC/MS [M+H]+=320, retention time=1.85 minutes.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07932282B2 |
|---|
| 出典データセット | uspto-grants-2011_04 |
|---|
| ORD ID | ord-b93ec2642cf64618bbe3c10313a46b46 |
|---|
| 出典メモ | uspto-grants-2011_04 |
|---|